Title  | Date  | Price |
|---|
Pharma Stulln GmbH-Company Report
| Sep 2009 |
£455 |
Pharis Biotec GmbH-Company Report
| Sep 2009 |
£455 |
Pharmaceutical Associates, Inc.-Company Report
| Sep 2009 |
£455 |
PharmaEngine, Inc.-Company Report
| Sep 2009 |
£455 |
Pharmagenesis Inc-Company Report
| Sep 2009 |
£455 |
Phafag AG-Company Report
| Sep 2009 |
£455 |
PH&T S.p.A.-Company Report
| Sep 2009 |
£455 |
Peptimmune, Inc-Company Report
| Sep 2009 |
£455 |
PepTx, Inc.-Company Report
| Sep 2009 |
£455 |
Pevion Biotech Ltd.-Company Report
| Sep 2009 |
£455 |
Pfizer Limited-Company Report
| Sep 2009 |
£455 |
PharmaIN Corporation-Company Report
| Sep 2009 |
£455 |
Pharmalink AB-Company Report
| Sep 2009 |
£455 |
Pharmstandard-Company Report
| Sep 2009 |
£455 |
Pharminox Ltd-Company Report
| Sep 2009 |
£455 |
Phase 2 Discovery, Inc.-Company Report
| Sep 2009 |
£455 |
Pherin Pharmaceuticals, Inc.-Company Report
| Sep 2009 |
£455 |
PhiloGene Inc.-Company Report
| Sep 2009 |
£455 |
PharmEste s.r.l.-Company Report
| Sep 2009 |
£455 |
Pharmbio Korea Co., Ltd-Company Report
| Sep 2009 |
£455 |
PharmaMar-Company Report
| Sep 2009 |
£455 |
Pharmaniaga Berhad-Company Report
| Sep 2009 |
£455 |
Pharmascience Inc.-Company Report
| Sep 2009 |
£455 |
Pharmathen S.A.-Company Report
| Sep 2009 |
£455 |
PepTcell Limited-Company Report
| Sep 2009 |
£455 |
Pei Li Pharmaceutical Ind. Co., Ltd.-Company Report
| Sep 2009 |
£455 |
Paladin Labs Inc.-Company Report
| Sep 2009 |
£455 |
PAION-Company Report
| Sep 2009 |
£455 |
PALAU PHARMA-Company Report
| Sep 2009 |
£455 |
Paloma Pharmaceuticals, Inc.-Company Report
| Sep 2009 |
£455 |
Pamlab, L.L.C. (formerly Pan American Laboratories, Inc.)-Company Report
| Sep 2009 |
£455 |
Paddock Laboratories, Inc.-Company Report
| Sep 2009 |
£455 |
Pacira Pharmaceuticals, Inc.-Company Report
| Sep 2009 |
£455 |
Pacgen Biopharmaceuticals Corporation-Company Report
| Sep 2009 |
£455 |
Ozone Laboratories SRL-Company Report
| Sep 2009 |
£455 |
Pacific Pharmaceutical Co., Ltd.-Company Report
| Sep 2009 |
£455 |
Pacific Pharmaceuticals Limited-Company Report
| Sep 2009 |
£455 |
Panacea Pharmaceuticals, Inc.-Company Report
| Sep 2009 |
£455 |
Panacea Biotec Ltd-Company Report
| Sep 2009 |
£455 |
Patrys Limited-Company Report
| Sep 2009 |
£455 |
PBN Pharma LLC-Company Report
| Sep 2009 |
£455 |
PDC Biotech GmbH-Company Report
| Sep 2009 |
£455 |
Pedinol Pharmacal Inc.-Company Report
| Sep 2009 |
£455 |
Pascual Laboratories Inc.-Company Report
| Sep 2009 |
£455 |
PARI Pharma (formerly PARI Aerosol Research Institute)-Company Report
| Sep 2009 |
£455 |
Pangenetics BV-Company Report
| Sep 2009 |
£455 |
Panjon Pharma Ltd.-Company Report
| Sep 2009 |
£455 |
Pantarhei Bioscience-Company Report
| Sep 2009 |
£455 |
Paratek Pharmaceuticals, Inc-Company Report
| Sep 2009 |
£455 |
Philusa Corporation-Company Report
| Sep 2009 |
£455 |
PhotoCure ASA-Company Report
| Sep 2009 |
£455 |
Plethico Pharmaceuticals Ltd.-Company Report
| Sep 2009 |
£455 |
Pisa Farmaceutica Mexicana-Company Report
| Sep 2009 |
£455 |
Plethora Solutions Limited-Company Report
| Sep 2009 |
£455 |
Polyphor Ltd-Company Report
| Sep 2009 |
£455 |
Prometheus Laboratories, Inc.-Company Report
| Sep 2009 |
£455 |
Piramal Healthcare Limited (formerly Nicholas Piramal India Limited)-Company Report
| Sep 2009 |
£455 |
Pinnacle Pharma del Peru S.A.C.-Company Report
| Sep 2009 |
£455 |
PLx Pharma Inc.-Company Report
| Sep 2009 |
£455 |
Polaris Group-Company Report
| Sep 2009 |
£455 |
Polpharma SA-Company Report
| Sep 2009 |
£455 |
Polymun Scientific Immunbiologische Forschung GmbH-Company Report
| Sep 2009 |
£455 |
ProMetic Life Sciences Inc.-Company Report
| Sep 2009 |
£455 |
Proneuron Biotechnologies, Inc.-Company Report
| Sep 2009 |
£455 |
Protemix Corporation Limited-Company Report
| Sep 2009 |
£455 |
Proteolix, Inc.-Company Report
| Sep 2009 |
£455 |
ProteomTech, Inc.-Company Report
| Sep 2009 |
£455 |
PharmEvo (Pvt.) Ltd.-Company Report
| Sep 2009 |
£460 |
Protein Sciences Corporation-Company Report
| Sep 2009 |
£455 |
ProtAffin Biotechnologie AG-Company Report
| Sep 2009 |
£455 |
Pronova BioPharma ASA-Company Report
| Sep 2009 |
£455 |
Proper Nutrition, Inc.-Company Report
| Sep 2009 |
£455 |
Proreo Pharma AG-Company Report
| Sep 2009 |
£455 |
ProStrakan Group plc-Company Report
| Sep 2009 |
£455 |
Plexxikon Inc-Company Report
| Sep 2009 |
£455 |
Prolysis Limited-Company Report
| Sep 2009 |
£455 |
PT Kimia Farma Tbk-Company Report
| Sep 2009 |
£455 |
PT Darya-Varia Laboratoria Tbk-Company Report
| Sep 2009 |
£455 |
PT. Pyridam Farma Tbk-Company Report
| Sep 2009 |
£455 |
Philogen S.p.A-Company Report
| Sep 2009 |
£455 |
Popular Pharmaceuticals Ltd.-Company Report
| Sep 2009 |
£455 |
PT Kalbe Farma Tbk.-Company Report
| Sep 2009 |
£455 |
Protox Therapeutics Inc.-Company Report
| Sep 2009 |
£455 |
Photopharmica Ltd-Company Report
| Sep 2009 |
£455 |
Phynova Group Plc-Company Report
| Sep 2009 |
£455 |
Pieris AG-Company Report
| Sep 2009 |
£455 |
Protez Pharmaceuticals-Company Report
| Sep 2009 |
£455 |
Portola Pharmaceuticals, Inc.-Company Report
| Sep 2009 |
£455 |
PR Pharmaceuticals, Inc.-Company Report
| Sep 2009 |
£455 |
Probiomed, S.A. de C.V-Company Report
| Sep 2009 |
£455 |
Probiotec Limited-Company Report
| Sep 2009 |
£455 |
Procaps SA-Company Report
| Sep 2009 |
£455 |
Prolexys Pharmaceuticals, Inc-Company Report
| Sep 2009 |
£455 |
Pro Vaccine AG-Company Report
| Sep 2009 |
£455 |
PRB Pharmaceuticals, Inc.-Company Report
| Sep 2009 |
£455 |
Prasco Laboratories-Company Report
| Sep 2009 |
£455 |
PregLem SA-Company Report
| Sep 2009 |
£455 |
Presidio Pharmaceuticals, Inc.-Company Report
| Sep 2009 |
£455 |
Primus Pharmaceuticals, Inc.-Company Report
| Sep 2009 |
£455 |
Phenomix Corporation-Company Report
| Sep 2009 |
£460 |
first
previous
